Atrial fibrillation burden during the coronavirus disease 2019 pandemic.
Catherine J O'SheaMelissa E MiddeldorpGijo ThomasCurtis HarperAdrian D ElliottNoemi RayKevin CampbellDennis H LauPrashanthan SandersPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
Australian New Zealand Clinical Trial Registry: ACTRN12620000692932.
Keyphrases
- coronavirus disease
- clinical trial
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- left atrial
- phase ii
- left atrial appendage
- direct oral anticoagulants
- respiratory syndrome coronavirus
- heart failure
- study protocol
- open label
- double blind
- percutaneous coronary intervention
- risk factors
- phase iii
- randomized controlled trial
- venous thromboembolism
- acute coronary syndrome
- left ventricular
- mitral valve